Abstract:BACKGROUND: A number of reports have suggested that many of the problems currently associated with the use of microneedle (MN) arrays for transdermal drug delivery could be addressed by using drug-loaded MN arrays prepared by moulding hot melts of carbohydrate materials.METHODS: In this study, we explored the processing, handling, and storage of MN arrays prepared from galactose with a view to clinical application.RESULTS: Galactose required a high processing temperature (160 degrees C), and molten galactose was difficult to work with. Substantial losses of the model drugs 5-aminolevulinic acid (ALA) and bovine serum albumin were incurred during processing. While relatively small forces caused significant reductions in MN height when applied to an aluminium block, this was not observed during their relatively facile insertion into heat-stripped epidermis. Drug release experiments using ALA-loaded MN arrays revealed that less than 0.05% of the total drug loading was released across a model silicone membrane. Similarly, only low amounts of ALA (approximately 0.13%) and undetectable amounts of bovine serum albumin were delivered when galactose arrays were combined with aqueous vehicles. Microscopic inspection of the membrane following release studies revealed that no holes could be observed in the membrane, indicating that the partially dissolved galactose sealed the MN-induced holes, thus limiting drug delivery. Indeed, depth penetration studies into excised porcine skin revealed that there was no significant increase in ALA delivery using galactose MN arrays, compared to control (P value < 0.05). Galactose MNs were unstable at ambient relative humidities and became adhesive.CONCLUSION: The processing difficulties and instability encountered in this study are likely to preclude successful clinical application of carbohydrate MNs. The findings of this study are of particular importance to those in the pharmaceutical industry involved in the design and formulation of transdermal drug delivery systems based on dissolving MN arrays. It is hoped that we have illustrated conclusively the difficulties inherent in the processing and storage of carbohydrate-based dissolving MNs and that those in the industry will now follow alternative approaches.

Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays

Ex vivo evaluation of a microneedle array device for transdermal application

Porous microneedle arrays as promising tools for the quantification of drugs in the skin: a proof of concept study

Parafilm® M and Strat-M® as skin simulants in in vitro permeation of dissolving microarray patches loaded with proteins

Processing difficulties and instability of carbohydrate microneedle arrays

Dissolvable microneedles in the skin: Determination the impact of barrier disruption and dry skin on dissolution

Microneedle arrays as medical devices for enhanced transdermal drug delivery

Comparing effects of terpene-based deep eutectic solvent and solid microneedles on skin permeation of drugs with varying lipophilicity

Modelling insertion behaviour of PVP (Polyvinylpyrrolidone) and PVA (Polyvinyl Alcohol) microneedles

Dissolvable microneedles for transdermal drug delivery showing skin pentation and modified drug release

Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application

Simulated skin model for in vitro evaluation of insertion performance of microneedles: design, development, and application verification

Modeling of Dissolving Microneedle-Based Transdermal Drug Delivery: Effects of Dynamics of Polymers in Solution

Microwave‐Assisted Preparation of Hydrogel‐Forming Microneedle Arrays for Transdermal Drug Delivery Applications

Modeling of Microneedle Arrays in Transdermal Drug Delivery Applications

Studies on drug delivery from dissolving microneedle and its uptake in tissue

Electrospun Fiber Dermal Model for Rapid in vitro Evaluation of Microneedle Patch

Effect of Microneedle Geometry and Supporting Substrate on Microneedle Array Penetration into Skin

Finite Element Analysis for Biodegradable Dissolving Microneedle Materials on Skin Puncture and Mechanical Performance Evaluation

Phase-transition microneedle patch for efficient transdermal delivery of bio-medicines

Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety